168 related articles for article (PubMed ID: 21181610)
41. Lynch syndrome: still not a familiar picture.
Hes FJ
World J Surg Oncol; 2008 Feb; 6():21. PubMed ID: 18284705
[TBL] [Abstract][Full Text] [Related]
42. Colonoscopy screening compliance and outcomes in patients with Lynch syndrome.
Newton K; Green K; Lalloo F; Evans DG; Hill J
Colorectal Dis; 2015 Jan; 17(1):38-46. PubMed ID: 25213040
[TBL] [Abstract][Full Text] [Related]
43. Lynch syndrome: clinical, pathological, and genetic insights.
Schneider R; Schneider C; Kloor M; Fürst A; Möslein G
Langenbecks Arch Surg; 2012 Apr; 397(4):513-25. PubMed ID: 22362054
[TBL] [Abstract][Full Text] [Related]
44. Immunohistochemical testing for colon cancer--what do New Zealand surgeons know?
Harper SJ; McEwen AR; Dennett ER
N Z Med J; 2010 Nov; 123(1325):35-40. PubMed ID: 21317959
[TBL] [Abstract][Full Text] [Related]
45. [Lynch syndrome: when pathologist and clinician have the opportunity to reduce the risk of developing cancer].
Genevay M; Benusiglio PR; Hutter P; Chappuis PO
Rev Med Suisse; 2011 Jul; 7(303):1502-6. PubMed ID: 21899217
[TBL] [Abstract][Full Text] [Related]
46. Surveillance in Lynch syndrome.
Mecklin JP; Järvinen HJ
Fam Cancer; 2005; 4(3):267-71. PubMed ID: 16136388
[TBL] [Abstract][Full Text] [Related]
47. [Cancer susceptibility and familial predisposition in colorectal cancer].
Gonda K; Sugano K
Nihon Rinsho; 2003 Sep; 61 Suppl 7():47-51. PubMed ID: 14574854
[No Abstract] [Full Text] [Related]
48. Re: Risks of colorectal and other cancers after endometrial cancer for women with Lynch syndrome.
Oktay AA; Alpay SN; Sahin IH
J Natl Cancer Inst; 2013 Dec; 105(23):1837. PubMed ID: 24168969
[No Abstract] [Full Text] [Related]
49. Surveillance colonoscopy practice in Lynch syndrome in the Netherlands: A nationwide survey.
Koornstra JJ; Vasen HF
World J Gastroenterol; 2007 Sep; 13(34):4658-9. PubMed ID: 17729427
[TBL] [Abstract][Full Text] [Related]
50. Mismatch repair deficiency in early-onset duodenal, ampullary, and pancreatic carcinomas is a strong indicator for a hereditary defect.
Kryklyva V; Brosens LA; Marijnissen-van Zanten MA; Ligtenberg MJ; Nagtegaal ID
J Pathol Clin Res; 2022 Mar; 8(2):181-190. PubMed ID: 34873870
[TBL] [Abstract][Full Text] [Related]
51. RE: Aspirin, Ibuprofen, and the Risk for Colorectal Cancer in Lynch Syndrome.
Tuccori M; Filion KB; Azoulay L
J Natl Cancer Inst; 2016 Feb; 108(2):. PubMed ID: 26711870
[No Abstract] [Full Text] [Related]
52. Lynch syndrome in patients with colorectal cancer: finding the needle in the haystack.
Ladabaum U; Ford JM
JAMA; 2012 Oct; 308(15):1581-3. PubMed ID: 23073955
[No Abstract] [Full Text] [Related]
53. Familial aggregation of tumors and detection of hereditary non-polyposis colorectal cancer in 3-year experience of 2 population-based colorectal-cancer registries.
Modica S; Roncucci L; Benatti P; Gafà L; Tamassia MG; Dardanoni L; Ponz de Leon M
Int J Cancer; 1995 Sep; 62(6):685-90. PubMed ID: 7558415
[TBL] [Abstract][Full Text] [Related]
54. Cancer Risk in Families Fulfilling the Amsterdam Criteria for Lynch Syndrome.
Samadder NJ; Smith KR; Wong J; Thomas A; Hanson H; Boucher K; Kopituch C; Cannon-Albright LA; Burt RW; Curtin K
JAMA Oncol; 2017 Dec; 3(12):1697-1701. PubMed ID: 28772302
[TBL] [Abstract][Full Text] [Related]
55. Family matters in lynch syndrome.
Kastrinos F; Steyerberg EW
J Natl Cancer Inst; 2015 Apr; 107(4):. PubMed ID: 25794515
[No Abstract] [Full Text] [Related]
56. A Practical Approach to the Evaluation of Gastrointestinal Tract Carcinomas for Lynch Syndrome.
Pai RK; Pai RK
Am J Surg Pathol; 2016 Apr; 40(4):e17-34. PubMed ID: 26974895
[TBL] [Abstract][Full Text] [Related]
57. Colorectal cancer screening.
Nelson RS; Thorson AG
Curr Oncol Rep; 2009 Nov; 11(6):482-9. PubMed ID: 19840526
[TBL] [Abstract][Full Text] [Related]
58. A new hereditary colorectal cancer network in the Middle East and eastern mediterranean countries to improve care for high-risk families.
Ghorbanoghli Z; Jabari C; Sweidan W; Hammoudeh W; Cortas G; Sharara AI; Abedrabbo A; Hourani I; Mahjoubi B; Majidzadeh K; Tözün N; Ziada-Bouchaar H; Hamoudi W; Diab O; Khorshid HRK; Lynch H; Vasen H
Fam Cancer; 2018 Apr; 17(2):209-212. PubMed ID: 28685475
[TBL] [Abstract][Full Text] [Related]
59. Evaluation of implementation of risk management guidelines for carriers of pathogenic variants in mismatch repair genes: a nationwide audit of familial cancer clinics.
Meiser B; Kaur R; Kirk J; Morrow A; Peate M; Wong WKT; McPike E; Cops E; Dowson C; Austin R; Fine M; Thrupp L; Ward R; Macrae F; Hiller JE; Trainer AH; Mitchell G;
Fam Cancer; 2020 Oct; 19(4):337-346. PubMed ID: 32385704
[TBL] [Abstract][Full Text] [Related]
60. Cancer risks after endometrial cancer in mismatch repair mutation carriers.
Lynch PM
J Natl Cancer Inst; 2013 Feb; 105(4):251-2. PubMed ID: 23385443
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
